Literature DB >> 19647005

Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia.

Monika Riek-Burchardt1, Angela Kolodziej, Petra Henrich-Noack, Klaus G Reymann, Volker Höllt, Ralf Stumm.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP) and the chemokine stromal cell-derived factor (SDF-1) have been implicated in neuroprotection, neurogenesis, and regeneration. Focal ischemia is associated with rapid upregulation of PACAP in perifocal neurons and delayed induction of SDF-1 in hypoxic/ischemic tissues, the latter process being involved in the recruitment of stem cells and inflammatory cells. Here, we studied mRNA patterns of PACAP, SDF-1 and the cognate receptors PAC1 and CXCR4 by in situ hybridization in the rat hippocampus after transient global ischemia, a rat model for programmed death of CA1 pyramidal neurons. Cell death in CA1 was not associated with local induction of PACAP and SDF-1 expression or recruitment of CXCR4-expressing infiltrates. However, there was a transient, almost complete loss of SDF-1 expression in microvessels in all hippocampal regions. Granule cells transiently showed a decrease of SDF-1 and an increase of PACAP expression. While PAC1 mRNA was moderately decreased throughout the hippocampus, CXCR4 expression was selectively increased in the subgranular layer. We propose that altered PACAP and SDF-1 gene expression in granule cells plays a role in regulated neurogenesis after global ischemia. The finding that programmed neuronal death after global ischemia was not associated with SDF-1 upregulation or recruitment of CXCR4-expressing cells is in sharp contrast to SDF-1/CXCR4-mediated infiltration of infarct tissue after focal ischemia. Hence, the different modes of neuronal death after focal and global ischemia are associated with distinct SDF-1 and PACAP gene regulation patterns and distinct reorganization mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647005     DOI: 10.1016/j.neuropharm.2009.07.032

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

2.  Distinctive properties of CXC chemokine receptor 4-expressing Cajal-Retzius cells versus GABAergic interneurons of the postnatal hippocampus.

Authors:  Ivan Marchionni; Virág T Takács; Maria Grazia Nunzi; Enrico Mugnaini; Richard J Miller; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

3.  Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.

Authors:  A Nemeth; K Szabadfi; B Fulop; D Reglodi; P Kiss; J Farkas; B Szalontai; R Gabriel; H Hashimoto; A Tamas
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

4.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

5.  Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.

Authors:  Ayako Miura; Yuki Kambe; Kazuhiko Inoue; Hideki Tatsukawa; Takashi Kurihara; Martin Griffin; Soichi Kojima; Atsuro Miyata
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

6.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

7.  Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Katarzyna Głombik; Katarzyna Chamera; Adam Roman; Bogusława Budziszewska; Agnieszka Basta-Kaim
Journal:  Neural Plast       Date:  2016-04-27       Impact factor: 3.599

Review 8.  A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Jakub Chwastek; Katarzyna Głombik; Agnieszka Basta-Kaim
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  PACAP Promotes Matrix-Driven Adhesion of Cultured Adult Murine Neural Progenitors.

Authors:  James A Waschek; Joseph R Cohen; Gloria C Chi; Tomasz J Proszynski; Pawel Niewiadomski
Journal:  ASN Neuro       Date:  2017 May-Jun       Impact factor: 4.146

Review 10.  Protective effects of PACAP in ischemia.

Authors:  Dora Reglodi; Alexandra Vaczy; Eloísa Rubio-Beltran; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2018-03-02       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.